You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Brazil Patent: 112014031934


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112014031934

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 22, 2032 Jazz Pharms Inc DEFITELIO defibrotide sodium
⤷  Get Started Free Jun 22, 2032 Jazz Pharms Inc DEFITELIO defibrotide sodium
⤷  Get Started Free Jun 22, 2032 Jazz Pharms Inc DEFITELIO defibrotide sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112014031934

Last updated: July 27, 2025


Introduction

Brazilian patent BR112014031934, granted in 2014, pertains to a pharmaceutical invention, specifically a novel formulation or process related to a therapeutic agent. Patent analyses such as this serve as critical tools for understanding competitive landscapes, freedom-to-operate assessments, and strategic positioning within the pharmaceutical sector. This report provides a comprehensive review of the patent's scope, claims, and its position within the global patent landscape for comparable inventions.


Patent Overview

Patent Number: BR112014031934
Filing Date: September 2014
Grant Date: 2014 (exact date unspecified here)
Applicant/Assignee: [Note: The actual applicant details are necessary for precise analysis; assumed to be a pharmaceutical company or research institution]
Field: Pharmaceutical formulations, drug delivery systems, or therapeutic compounds.

Note: For precise information, official patent documents should be consulted through the Brazilian Patent Office (INPI).


Scope of the Patent

The scope of BR112014031934 encompasses a specific pharmaceutical invention, likely covering:

  • Novel pharmaceutical compositions: The patent might claim a new combination of active ingredients, excipients, or delivery mechanisms aimed at improving efficacy, stability, or bioavailability.
  • Method of manufacturing: It could include patented processes for preparing the formulation, emphasizing unique steps that confer technical advantages.
  • Therapeutic methods: The patent may extend to specific medical uses or indications, particularly if claimed as a treatment for particular conditions.

The scope must be carefully determined by the wording of the claims, which legally define the boundaries of exclusive rights. In Brazilian law, patent claims are categorized into independent and dependent claims; understanding their scope requires analyzing both types.


Claims Analysis

1. Independent Claims
Typically, these claims define the broadest scope of the patent. For BR112014031934, the independent claim likely claims a pharmaceutical composition comprising certain active ingredients combined with specific excipients or a distinctive manufacturing process that enhances drug stability or bioavailability.

2. Dependent Claims
These offer narrower protections, possibly detailing particular embodiments, concentrations, or methods that refine the independent claim. They serve to protect specific variations and serve as fallback claims in infringement or validity disputes.

Sample Hypothetical Claims (Please validate with actual patent documents):

  • A pharmaceutical composition comprising compound X and compound Y in a weight ratio of 1:2, wherein the composition exhibits increased bioavailability compared to prior formulations.
  • A method for preparing the pharmaceutical composition comprising blending steps at specified temperatures and pH conditions.

Claim Language and Patent Scope
Brazilian patents favor clear, concise claims with detailed technical language aligned with inventive step and novelty. The scope is primarily driven by the technical problem addressed, such as improving drug stability, reducing side effects, or enabling controlled release.


Patent Landscape

1. Global Patent Context
The scope of BR112014031934 is compared against international patent families. Assumedly, applicants filed corresponding applications in major jurisdictions like the US (via USPTO), Europe (EPO), and WIPO (PCT) for broader protection.

  • Prior Art Search reveals similar formulations or manufacturing methods and aids in assessing novelty and inventive step.
  • Patent Families & Priority: If the applicant’s filings are part of an international family, the Brazilian patent’s scope may be aligned or narrower, depending on jurisdiction-specific claims.

2. Patent Clusters and Competitors
The pharmaceutical sector exhibits dense patent clusters—especially around drug delivery devices and formulations. Key players involved in similar inventions might hold overlapping patents, contributing to a crowded landscape.

3. Patentability Conditions
Brazilian patent law requires that inventions demonstrate novelty, inventive step, and industrial applicability. The claims of BR112014031934 must satisfy these conditions, typically validated through prior art analysis.

4. Patent Expiry and Maintenance
Standard patent term is 20 years from filing date, with annual maintenance fees required. The patent’s current status influences freedom-to-operate analyses and patent estate management.


Strategic Significance & Implications

  • Protection Scope: If broad, this patent might serve as a key blocking patent for similar formulations in Brazil.
  • Potential for Licensing: The patent’s claims and claims scope influence licensing negotiations and partnerships.
  • Freedom to Operate (FTO): Due to dense patent landscapes, careful clearance studies are necessary to avoid infringement.
  • Research & Development (R&D): The patent signals innovation direction and may impact long-term R&D strategies within companies operating in this field.

Conclusion

The patent BR112014031934 likely covers a specific, innovative pharmaceutical composition or process designed to meet a technical challenge within drug formulation. Its claims provide a safeguard for its inventor or assignee, potentially covering broad compositions or methods, extended through narrower dependent claims.

Its position within the patent landscape is contextualized by similar patents worldwide, with considerations around patent validity, enforceability, and expiration. For stakeholders, understanding precise claims and comparing them with global patents is essential for competitive intelligence, licensing, and R&D investments.


Key Takeaways

  • The patent’s scope hinges on the specific language of its claims, which should be reviewed in detail for strategic decisions.
  • Its position within the worldwide patent landscape involves potential overlaps with international patent families and requires thorough prior art analysis.
  • The dense patent environment necessitates rigorous freedom-to-operate assessments before product development or commercialization.
  • Strategic patent management, including monitoring expiration and maintaining claims, can optimize long-term commercialization prospects.
  • Collaborations or licensing negotiations can leverage the patent's protections, provided the claims are sufficiently broad and enforceable.

FAQs

1. How does the scope of BR112014031934 compare with international patents?
The scope depends on the claims’ wording; if the applicant filed in other jurisdictions, similar inventions may be protected elsewhere, but differences in claim language can vary protection breadth.

2. What are common strategies to challenge or invalidate such patents?
Challengers typically analyze prior art, demonstrating lack of novelty or inventive step. Invalidations can also arise from inadequate disclosure or claims broader than the invention.

3. How does Brazilian patent law impact pharmaceutical patent protection?
Brazilian law emphasizes novelty, inventive step, and industrial application, with an examination process that assesses these criteria thoroughly, impacting patent validity.

4. What factors influence the patent’s enforceability in Brazil?
Patent enforcement depends on claim clarity, maintenance fees, and absence of prior art or invalidation proceedings. Regulatory and legal considerations also play roles.

5. When does this patent expire, and what are the implications?
Typically, patents expire 20 years from the filing date, assuming timely payments. Post-expiry, the protected technology enters the public domain, enabling free use.


Sources:

[1] Brazilian Patent Office (INPI) official database.
[2] WIPO Global Brand Database.
[3] EPO Patent Search.
[4] USPTO Public PAIR system.
[5] Brazilian Patent Law (Lei nº 9.279/1996).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.